|
|
|
|
Дата |
|---|
| 16.07.2026 |
| 15.07.2026 |
| 14.07.2026 |
| 13.07.2026 |
| 12.07.2026 |
| 09.07.2026 |
| 08.07.2026 |
| 07.07.2026 |
| 06.07.2026 |
| 05.07.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
88.31
|
88.05
|
90.48
|
88.97
|
|
|
58 826 554.26
|
1 148.00
|
|
|
|
86.47
|
86.00
|
89.49
|
88.31
|
|
|
70 284 925.04
|
1 152.00
|
|
|
|
85.80
|
85.40
|
86.47
|
86.47
|
|
|
6 206 845.49
|
275.00
|
|
|
|
86.07
|
85.40
|
87.00
|
85.80
|
|
|
17 631 735.59
|
768.00
|
|
|
|
86.09
|
86.03
|
87.65
|
86.07
|
|
|
6 405 126.74
|
348.00
|
|
|
|
87.00
|
86.00
|
87.50
|
86.09
|
|
|
8 601 846.00
|
338.00
|
|
|
|
87.49
|
86.60
|
88.10
|
87.00
|
|
|
8 923 885.26
|
278.00
|
|
|
|
88.00
|
87.01
|
88.80
|
87.49
|
|
|
7 440 911.77
|
298.00
|
|
|
|
88.87
|
87.50
|
88.80
|
88.00
|
|
|
13 624 075.20
|
357.00
|
|
|
|
88.21
|
88.21
|
89.33
|
88.87
|
|
|
7 628 455.10
|
362.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
26.04.2026
|
27.04.2026 |
3.5 EGP |
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
